赛托生物(300583.SZ)取得倍他米松原料药CEP证书

Core Viewpoint - The company has received the CEP certificate for the active pharmaceutical ingredient Betamethasone, allowing it to sell in international markets that recognize the certificate, which will positively impact its market expansion and competitiveness in the chemical raw materials sector [1]. Group 1 - The company's subsidiary, Shandong Sry Pharmaceutical Co., Ltd., has obtained the CEP certificate from the European Directorate for the Quality of Medicines (EDQM) [1]. - The certificate pertains to the chemical raw material Betamethasone [1]. - The acquisition of the CEP certificate is expected to enhance the company's product line and market competitiveness in the chemical raw materials field [1].